28 results on '"Izzi V."'
Search Results
2. Matrisome AnalyzeR:a suite of tools to annotate and quantify ECM molecules in big datasets across organisms
- Author
-
Petrov, P. B. (Petar B.), Considine, J. M. (James M.), Izzi, V. (Valerio), Naba, A. (Alexandra), Petrov, P. B. (Petar B.), Considine, J. M. (James M.), Izzi, V. (Valerio), and Naba, A. (Alexandra)
- Abstract
The extracellular matrix (ECM) is a complex meshwork of proteins that forms the scaffold of all tissues in multicellular organisms. It plays crucial roles in all aspects of life — from orchestrating cell migration during development, to supporting tissue repair. It also plays critical roles in the etiology or progression of diseases. To study this compartment, we have previously defined the compendium of all genes encoding ECM and ECM-associated proteins for multiple organisms. We termed this compendium the ‘matrisome’ and further classified matrisome components into different structural or functional categories. This nomenclature is now largely adopted by the research community to annotate ‘-omics’ datasets and has contributed to advance both fundamental and translational ECM research. Here, we report the development of Matrisome AnalyzeR, a suite of tools including a web-based application and an R package. The web application can be used by anyone interested in annotating, classifying and tabulating matrisome molecules in large datasets without requiring programming knowledge. The companion R package is available to more experienced users, interested in processing larger datasets or in additional data visualization options.
- Published
- 2023
3. Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression
- Author
-
Rafaeva, M. (Maria), Jensen, A. R. (Adina R. D.), Horton, E. R. (Edward R.), Zornhagen, K. W. (Kamilla W.), Strøbech, J. E. (Jan E.), Fleischhauer, L. (Lutz), Mayorca-Guiliani, A. E. (Alejandro E.), Nielsen, S. R. (Sebastian R.), Grønseth, D. S. (Dina S.), Kuś, F. (Filip), Schoof, E. M. (Erwin M.), Arnes, L. (Luis), Koch, M. (Manuel), Clausen-Schaumann, H. (Hauke), Izzi, V. (Valerio), Reuten, R. (Raphael), Erler, J. T. (Janine T.), Rafaeva, M. (Maria), Jensen, A. R. (Adina R. D.), Horton, E. R. (Edward R.), Zornhagen, K. W. (Kamilla W.), Strøbech, J. E. (Jan E.), Fleischhauer, L. (Lutz), Mayorca-Guiliani, A. E. (Alejandro E.), Nielsen, S. R. (Sebastian R.), Grønseth, D. S. (Dina S.), Kuś, F. (Filip), Schoof, E. M. (Erwin M.), Arnes, L. (Luis), Koch, M. (Manuel), Clausen-Schaumann, H. (Hauke), Izzi, V. (Valerio), Reuten, R. (Raphael), and Erler, J. T. (Janine T.)
- Abstract
The desmoplastic reaction observed in many cancers is a hallmark of disease progression and prognosis, particularly in breast and pancreatic cancer. Stromal-derived extracellular matrix (ECM) is significantly altered in desmoplasia, and as such plays a critical role in driving cancer progression. Using fibroblast-derived matrices (FDMs), we show that cancer cells have increased growth on cancer associated FDMs, when compared to FDMs derived from non-malignant tissue (normal) fibroblasts. We assess the changes in ECM characteristics from normal to cancer-associated stroma at the primary tumor site. Compositional, structural, and mechanical analyses reveal significant differences, with an increase in abundance of core ECM proteins, coupled with an increase in stiffness and density in cancer-associated FDMs. From compositional changes of FDM, we derived a 36-ECM protein signature, which we show matches in large part with the changes in pancreatic ductal adenocarcinoma (PDAC) tumor and metastases progression. Additionally, this signature also matches at the transcriptomic level in multiple cancer types in patients, prognostic of their survival. Together, our results show relevance of FDMs for cancer modelling and identification of desmoplastic ECM components for further mechanistic studies.
- Published
- 2023
4. The alternative matrisome:alternative splicing of ECM proteins in development, homeostasis and tumor progression
- Author
-
Rekad, Z. (Zeinab), Izzi, V. (Valerio), Lamba, R. (Rijuta), Ciais, D. (Delphine), Van Obberghen-Schilling, E. (Ellen), Rekad, Z. (Zeinab), Izzi, V. (Valerio), Lamba, R. (Rijuta), Ciais, D. (Delphine), and Van Obberghen-Schilling, E. (Ellen)
- Abstract
The extracellular matrix (ECM) is a fundamental component of the tissue of multicellular organisms that is comprised of an intricate network of multidomain proteins and associated factors, collectively known as the matrisome. The ECM creates a biophysical environment that regulates essential cellular processes such as adhesion, proliferation and migration and impacts cell fate decisions. The composition of the ECM varies across organs, developmental stages and diseases. Interestingly, most ECM genes generate transcripts that undergo extensive alternative splicing events, producing multiple protein variants from one gene thus enhancing ECM complexity and impacting matrix architecture. Extensive studies over the past several decades have linked ECM remodeling and expression of alternatively spliced ECM isoforms to cancer, and reprogramming of the alternative splicing patterns in cells has recently been proposed as a new hallmark of tumor progression. Indeed, tumor-associated alternative splicing occurs in both malignant and non-malignant cells of the tumor environment and growing evidence suggests that expression of specific ECM splicing variants could be a key step for stromal activation. In this review, we present a general overview of alternative splicing mechanisms, featuring examples of ECM components. The importance of ECM variant expression during essential physiological processes, such as tissue organization and embryonic development is discussed as well as the dysregulation of alternative splicing in cancer. The overall aim of this review is to address the complexity of the ECM by highlighting the importance of the yet-to-be-fully-characterized “alternative” matrisome in physiological and pathological states such as cancer.
- Published
- 2022
5. The CMS19 disease model specifies a pivotal role for collagen XIII in bone homeostasis
- Author
-
Kemppainen, A. V. (A. V.), Finnilä, M. A. (M. A.), Heikkinen, A. (A.), Härönen, H. (H.), Izzi, V. (V.), Kauppinen, S. (S.), Saarakkala, S. (S.), Pihlajaniemi, T. (T.), Koivunen, J. (J.), Kemppainen, A. V. (A. V.), Finnilä, M. A. (M. A.), Heikkinen, A. (A.), Härönen, H. (H.), Izzi, V. (V.), Kauppinen, S. (S.), Saarakkala, S. (S.), Pihlajaniemi, T. (T.), and Koivunen, J. (J.)
- Abstract
Mutations in the COL13A1 gene result in congenital myasthenic syndrome type 19 (CMS19), a disease of neuromuscular synapses and including various skeletal manifestations, particularly facial dysmorphisms. The phenotypic consequences in Col13a1 null mice (Col13a1−/−) recapitulate the muscle findings of the CMS19 patients. Collagen XIII (ColXIII) is exists as two forms, a transmembrane protein and a soluble molecule. While the Col13a1−/− mice have poorly formed neuromuscular junctions, the prevention of shedding of the ColXIII ectodomain in the Col13a1tm/tm mice results in acetylcholine receptor clusters of increased size and complexity. In view of the bone abnormalities in CMS19, we here studied the tubular and calvarial bone morphology of the Col13a1−/− mice. We discovered several craniofacial malformations, albeit less pronounced ones than in the human disease, and a reduction of cortical bone mass in aged mice. In the Col13a1tm/tm mice, where ColXIII is synthesized but the ectodomain shedding is prevented due to a mutation in a protease recognition sequence, the cortical bone mass decreased as well with age and the cephalometric analyses revealed significant craniofacial abnormalities but no clear phenotypical pattern. To conclude, our data indicates an intrinsic role for ColXIII, particularly the soluble form, in the upkeep of bone with aging and suggests the possibility of previously undiscovered bone pathologies in patients with CMS19.
- Published
- 2022
6. Cooperation of angiopoietin-2 and angiopoietin-4 in Schlemm’s canal maintenance
- Author
-
Kapiainen, E. (Emmi), Elamaa, H. (Harri), Miinalainen, I. (Ilkka), Izzi, V. (Valerio), Eklund, L. (Lauri), Kapiainen, E. (Emmi), Elamaa, H. (Harri), Miinalainen, I. (Ilkka), Izzi, V. (Valerio), and Eklund, L. (Lauri)
- Abstract
Purpose: Defects in the iridocorneal angle tissues, including the trabecular meshwork (TM) and Schlemm’s canal (SC), impair aqueous humor flow and increase the intraocular pressure (IOP), eventually resulting in glaucoma. Activation of endothelial tyrosine kinase receptor Tie2 by angiopoietin-1 (Angpt1) has been demonstrated to be essential for SC formation, but roles of the other two Tie2 ligands, Angpt2 and Angpt4, have been controversial or not yet characterized, respectively. Methods: Angpt4 expression was investigated using genetic cell fate mapping and reporter mice. Congenital deletion of Angpt2 and Angpt4 and tamoxifen-inducible deletion of Angpt1 in mice were used to study the effects of Angpt4 deletion alone and in combination with the other angiopoietins. SC morphology was examined with immunofluorescent staining. IOP measurements, electron microscopy, and histologic evaluation were used to study glaucomatous changes. Results: Angpt4 was postnatally expressed in the TM. While Angpt4 deletion alone did not affect SC and Angpt4 deletion did not aggravate Angpt1 deletion phenotype, absence of Angpt4 combined with Angpt2 deletion had detrimental effects on SC morphology in adult mice. Consequently, Angpt2−/−;Angpt4−/− mice displayed glaucomatous changes in the eye. Mice with Angpt2 deletion alone showed only moderate SC defects, but Angpt2 was necessary for proper limbal vasculature development. Mechanistically, analysis of Tie2 phosphorylation suggested that Angpt2 and Angpt4 cooperate as agonistic Tie2 ligands in maintaining SC integrity. Conclusions: Our results indicated an additive effect of Angpt4 in SC maintenance and Tie2 activation and a spatiotemporally regulated interplay between the angiopoietins in the mouse iridocorneal angle.
- Published
- 2022
7. Corrigendum to “Evidence for discrete modes of YAP1 signaling via mRNA splice isoforms in development and disease” [Genomics 113 (2021) 1349–1365]
- Author
-
Vrbský, J. (Jan), Vinarský, V. (Vladimir), Perestrelo, A. R. (Ana Rubina), Oliver-De La Cruz, J. (Jorge), Martino, F. (Fabiana), Pompeiano, A. (Antonio), Izzi, V. (Valerio), Hlinomaz, O. (Ota), Rotrekl, V. (Vladimir), Sudol, M. (Marius), Pagliari, S. (Stefania), Forte, G. (Giancarlo), Vrbský, J. (Jan), Vinarský, V. (Vladimir), Perestrelo, A. R. (Ana Rubina), Oliver-De La Cruz, J. (Jorge), Martino, F. (Fabiana), Pompeiano, A. (Antonio), Izzi, V. (Valerio), Hlinomaz, O. (Ota), Rotrekl, V. (Vladimir), Sudol, M. (Marius), Pagliari, S. (Stefania), and Forte, G. (Giancarlo)
- Abstract
Correction to: Vrbský, J., Vinarský, V., Perestrelo, A. R., De La Cruz, J. O., Martino, F., Pompeiano, A., Izzi, V., Hlinomaz, O., Rotrekl, V., Sudol, M., Pagliari, S., & Forte, G. (2021). Evidence for discrete modes of YAP1 signaling via mRNA splice isoforms in development and diseases. Genomics, 113(3), 1349–1365. https://doi.org/10.1016/j.ygeno.2021.03.009 Rinnakkaistallennettu versio / Self-archived version
- Published
- 2022
8. Advances on the roles of tenascin-C in cancer
- Author
-
Yilmaz, A. (Alev), Loustau, T. (Thomas), Salomé, N. (Nathalie), Poilil Surendran, S. (Suchithra), Li, C. (Chengbei), Tucker, R. P. (Richard P.), Izzi, V. (Valerio), Lamba, R. (Rijuta), Koch, M. (Manuel), Orend, G. (Gertraud), Yilmaz, A. (Alev), Loustau, T. (Thomas), Salomé, N. (Nathalie), Poilil Surendran, S. (Suchithra), Li, C. (Chengbei), Tucker, R. P. (Richard P.), Izzi, V. (Valerio), Lamba, R. (Rijuta), Koch, M. (Manuel), and Orend, G. (Gertraud)
- Abstract
The roles of the extracellular matrix molecule tenascin-C (TNC) in health and disease have been extensively reviewed since its discovery over 40 years ago. Here, we will describe recent insights into the roles of TNC in tumorigenesis, angiogenesis, immunity and metastasis. In addition to high levels of expression in tumors, and during chronic inflammation, and bacterial and viral infection, TNC is also expressed in lymphoid organs. This supports potential roles for TNC in immunity control. Advances using murine models with engineered TNC levels were instrumental in the discovery of important functions of TNC as a danger-associated molecular pattern (DAMP) molecule in tissue repair and revealed multiple TNC actions in tumor progression. TNC acts through distinct mechanisms on many different cell types with immune cells coming into focus as important targets of TNC in cancer. We will describe how this knowledge could be exploited for cancer disease management, in particular for immune (checkpoint) therapies.
- Published
- 2022
9. Analysis of extracellular matrix network dynamics in cancer using the MatriNet database
- Author
-
Kontio, J. (Juho), Soñora, V. R. (Valeria Rolle), Pesola, V. (Vilma), Lamba, R. (Rijuta), Dittmann, A. (Annalena), Navarro, A. D. (Ander Diaz), Koivunen, J. (Jarkko), Pihlajaniemi, T. (Taina), Izzi, V. (Valerio), Kontio, J. (Juho), Soñora, V. R. (Valeria Rolle), Pesola, V. (Vilma), Lamba, R. (Rijuta), Dittmann, A. (Annalena), Navarro, A. D. (Ander Diaz), Koivunen, J. (Jarkko), Pihlajaniemi, T. (Taina), and Izzi, V. (Valerio)
- Abstract
The extracellular matrix (ECM) is a three-dimensional network of proteins of diverse nature, whose interactions are essential to provide tissues with the correct mechanical and biochemical cues they need for proper development and homeostasis. Changes in the quantity of extracellular matrix (ECM) components and their balance within the tumor microenvironment (TME) accompany and fuel all steps of tumor development, growth and metastasis, and a deeper and more systematic understanding of these processes is fundamental for the development of future therapeutic approaches. The wealth of “big data” from numerous sources has enabled gigantic steps forward in the comprehension of the oncogenic process, also impacting on our understanding of ECM changes in the TME. Most of the available studies, however, have not considered the network nature of ECM and the possibility that changes in the quantity of components might be regulated (co-occur) in cancer and significantly “rebound” on the whole network through its connections, fundamentally altering the matrix interactome. To facilitate the exploration of these network-scale effects we have implemented MatriNet (www.matrinet.org), a database enabling the study of structural changes in ECM network architectures as a function of their protein-protein interaction strengths across 20 different tumor types. The use of MatriNet is intuitive and offers new insights into tumor-specific as well as pan-cancer features of ECM networks, facilitating the identification of similarities and differences between cancers as well as the visualization of single-tumor events and the prioritization of ECM targets for further experimental investigations.
- Published
- 2022
10. Mutations in the COL18A1 gen associated with knobloch syndrome and structural brain anomalies:a novel case report and literature review of neuroimaging findings
- Author
-
García-Prieto, I. I. (I Irene Díez), Lopez-Martín, S. (Sara), Albert, J. (Jacobo), de la Peña, M. J. (Mar Jiménez), Fernández-Mayoralas, D. M. (Daniel Martín), Calleja-Pérez, B. (Beatriz), Fernández, M. T. (María Teresa Gómez), Álvarez, S. (Sara), Pihlajaniemi, T. (Taina), Izzi, V. (Valerio), Fernández-Jaén, A. (Alberto), García-Prieto, I. I. (I Irene Díez), Lopez-Martín, S. (Sara), Albert, J. (Jacobo), de la Peña, M. J. (Mar Jiménez), Fernández-Mayoralas, D. M. (Daniel Martín), Calleja-Pérez, B. (Beatriz), Fernández, M. T. (María Teresa Gómez), Álvarez, S. (Sara), Pihlajaniemi, T. (Taina), Izzi, V. (Valerio), and Fernández-Jaén, A. (Alberto)
- Abstract
COL18A1 gene mutations have been associated with Knobloch syndrome, which is characterized by ocular and brain abnormalities. Here we report a 4.5 years-old male child with autism and two novel COL18A1 mutations (NM_030582.4: c.1883_1891dup and c.1787C>T). Hypermetropic astigmatism, but not brain migration disorders, was observed. However, an asymmetric pattern of cerebellar perfusion and a smaller arcuate fascicle were found. Low levels of collagen XVIII were also observed in the patient’s serum. Thus, biallelic loss-of-function mutations in COL18A1 may be a new cause of autism without the brain malformations typically reported in patients with Knobloch syndrome.
- Published
- 2022
11. Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis
- Author
-
Martínez-Nieto, G. A. (Guillermo A.), Teppo, H.-R. (Hanna-Riikka), Petrelius, N. (Noora), Izzi, V. (Valerio), Devarajan, R. (Raman), Petäistö, T. (Tiina), Liu, H. (Hengshuo), Kim, K. S. (Kris S.), Karppinen, S.-M. (Sanna-Maria), Ruotsalainen, H. (Heli), Koivunen, J. (Jarkko), Mäki, J. M. (Joni M.), Walker, G. C. (Gilbert C.), Pihlajaniemi, T. (Taina), Gullberg, D. (Donald), and Heljasvaara, R. (Ritva)
- Abstract
Integrin α11β1 is a collagen-binding integrin that is needed to induce and maintain the myofibroblast phenotype in fibrotic tissues and during wound healing. The expression of the α11 is upregulated in cancer-associated fibroblasts (CAFs) in various human neoplasms. We investigated α11 expression in human cutaneous squamous cell carcinoma (cSCC) and in benign and premalignant human skin lesions and monitored its effects on cSCC development by subjecting α11-knockout (Itga11−/−) mice to the DMBA/TPA skin carcinogenesis protocol. α11-deficient mice showed significantly decreased tumor cell proliferation, leading to delayed tumor development and reduced tumor burden. Integrin α11 expression was significantly upregulated in the desmoplastic tumor stroma of human and mouse cSCCs, and the highest α11 expression was detected in high-grade tumors. Our results point to a reduced ability of α11-deficient stromal cells to differentiate into matrix-producing and tumor-promoting CAFs and suggest that this is one causative mechanism underlying the observed decreased tumor growth. An unexpected finding in our study was that, despite reduced CAF activation, the α11-deficient skin tumors were characterized by the presence of thick and regularly aligned collagen bundles. This finding was attributed to a higher expression of TGFβ1 and collagen crosslinking lysyl oxidases in the Itga11−/− tumor stroma. In summary, our data suggest that α11β1 operates in a complex interactive tumor environment to regulate ECM synthesis and collagen organization and thus foster cSCC growth. Further studies with advanced experimental models are still needed to define the exact roles and molecular mechanisms of stromal α11β1 in skin tumorigenesis.
- Published
- 2022
12. Reduced bone mass in collagen prolyl 4-hydroxylase P4ha1+/-; P4ha2-/- compound mutant mice
- Author
-
Tolonen, J.-P. (Jussi-Pekka), Salo, A. M. (Antti M.), Finnilä, M. (Mikko), Aro, E. (Ellinoora), Karjalainen, E. (Emma), Ronkainen, V.-P. (Veli-Pekka), Drushinin, K. (Kati), Merceron, C. (Christophe), Izzi, V. (Valerio), Schipani, E. (Ernestina), and Myllyharju, J. (Johanna)
- Subjects
collagen ,bone μct ,genetic animal models ,osteoblasts ,bone histomorphometry - Abstract
Proper deposition of the extracellular matrix and its major components, the collagens, is essential for endochondral ossification and bone mass accrual. Collagen prolyl 4-hydroxylases (C-P4Hs) hydroxylate proline residues in the -X-Pro-Gly- repeats of all known collagen types. Their product, 4-hydroxyproline, is essential for correct folding and thermal stability of the triple-helical collagen molecules in physiological body temperatures. We have previously shown that inactivation of the mouse P4ha1 gene, which codes for the catalytic α subunit of the major C-P4H isoform, is embryonic lethal, whereas inactivation of the P4ha2 gene produced only a minor phenotype. Instead, mice with a haploinsufficiency of the P4ha1 gene combined with a homozygous deletion of the P4ha2 gene present with a moderate chondrodysplasia due to transient cell death of the growth plate chondrocytes. Here, to further characterize the bone phenotype of the P4ha1+/−; P4ha2−/− mice, we have carried out gene expression analyses at whole-tissue and single-cell levels, biochemical analyses, microcomputed tomography, histomorphometric analyses, and second harmonic generation microscopy to show that C-P4H α subunit expression peaks early and that the C-P4H deficiency leads to reduced collagen amount, a reduced rate of bone formation, and a loss of trabecular and cortical bone volume in the long bones. The total osteoblast number in the proximal P4ha1+/−; P4ha2−/− tibia and the C-P4H activity in primary P4ha1+/−; P4ha2−/− osteoblasts were reduced, whereas the population of osteoprogenitor colony-forming unit fibroblasts was increased in the P4ha1+/−; P4ha2−/− marrow. Thus, the P4ha1+/−; P4ha2−/− mouse model recapitulates key aspects of a recently recognized congenital connective tissue disorder with short stature and bone dysplasia caused by biallelic variants of the human P4HA1 gene. Altogether, the data demonstrate the allele dose-dependent importance of the C-P4Hs to the developing organism and a threshold effect of C-P4H activity in the proper production of bone matrix.
- Published
- 2022
13. 3DMOUSEneST: a volumetric label-free imaging method evaluating embryo-uterine interaction and decidualization efficacy.
- Author
-
Savolainen A, Kapiainen E, Ronkainen VP, Izzi V, Matzuk MM, Monsivais D, and Prunskaite-Hyyryläinen R
- Subjects
- Animals, Female, Pregnancy, Mice, Uterus physiology, Embryo, Mammalian, Mice, Knockout, Imaging, Three-Dimensional methods, Mice, Inbred C57BL, Embryo Implantation physiology, Decidua
- Abstract
Effective interplay between the uterus and the embryo is essential for pregnancy establishment; however, convenient methods to screen embryo implantation success and maternal uterine response in experimental mouse models are currently lacking. Here, we report 3DMOUSEneST, a groundbreaking method for analyzing mouse implantation sites based on label-free higher harmonic generation microscopy, providing unprecedented insights into the embryo-uterine dynamics during early pregnancy. The 3DMOUSEneST method incorporates second-harmonic generation microscopy to image the three-dimensional structure formed by decidual fibrillar collagen, named 'decidual nest', and third-harmonic generation microscopy to evaluate early conceptus (defined as the embryo and extra-embryonic tissues) growth. We demonstrate that decidual nest volume is a measurable indicator of decidualization efficacy and correlates with the probability of early pregnancy progression based on a logistic regression analysis using Smad1/5 and Smad2/3 conditional knockout mice with known implantation defects. 3DMOUSEneST has great potential to become a principal method for studying decidual fibrillar collagen and characterizing mouse models associated with early embryonic lethality and fertility issues., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2024. Published by The Company of Biologists Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
14. Collagen XVIII regulates extracellular matrix integrity in the developing nephrons and impacts nephron progenitor cell behavior.
- Author
-
Rinta-Jaskari MM, Naillat F, Ruotsalainen HJ, Ronkainen VP, Heljasvaara R, Akram SU, Izzi V, Miinalainen I, Vainio SJ, and Pihlajaniemi TA
- Subjects
- Animals, Mice, Cell Proliferation, Protein Isoforms genetics, Protein Isoforms metabolism, Collagen metabolism, Collagen genetics, Nephrons metabolism, Nephrons cytology, Nephrons growth & development, Extracellular Matrix metabolism, Stem Cells metabolism, Stem Cells cytology, Mice, Knockout
- Abstract
Renal development is a complex process in which two major processes, tubular branching and nephron development, regulate each other reciprocally. Our previous findings have indicated that collagen XVIII (ColXVIII), an extracellular matrix protein, affects the renal branching morphogenesis. We investigate here the role of ColXVIII in nephron formation and the behavior of nephron progenitor cells (NPCs) using isoform-specific ColXVIII knockout mice. The results show that the short ColXVIII isoform predominates in the early epithelialized nephron structures whereas the two longer isoforms are expressed only in the later phases of glomerular formation. Meanwhile, electron microscopy showed that the ColXVIII mutant embryonic kidneys have ultrastructural defects at least from embryonic day 16.5 onwards. Similar structural defects had previously been observed in adult ColXVIII-deficient mice, indicating a congenital origin. The lack of ColXVIII led to a reduced NPC population in which changes in NPC proliferation and maintenance and in macrophage influx were perceived to play a role. The changes in NPC behavior in turn led to notably reduced overall nephron formation. In conclusion, the results show that ColXVIII has multiple roles in renal development, both in ureteric branching and in NPC behavior., Competing Interests: Declaration of competing interest There are no competing interests to declare., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. Novel Genetic Variants Associated with Primary Myocardial Fibrosis in Sudden Cardiac Death Victims.
- Author
-
Skarp S, Doedens A, Holmström L, Izzi V, Saarimäki S, Sliz E, Kettunen J, Pakanen L, Kerkelä R, Pylkäs K, Huikuri HV, Myerburg RJ, and Junttila J
- Abstract
Myocardial fibrosis is a common finding in victims of sudden cardiac death (SCD). Whole exome sequencing was performed in 127 victims of SCD with primary myocardial fibrosis as the only pathological finding. These cases are derived from the Fingesture study which has collected data from autopsy-verified SCD victims in Northern Finland. A computational approach was used to identify protein interactions in cardiomyocytes. Associations of the identified variants with cardiac disease endpoints were investigated in the Finnish national genetic study (FinnGen) dataset. We identified 21 missense and one nonsense variant. Four variants were estimated to affect protein function, significantly associated with SCD/primary myocardial fibrosis (Fingesture) and associated with cardiac diseases in Finnish population (FinnGen). These variants locate in cartilage acidic protein 1 (CRATC1), calpain 1 (CAPN1), unc-45 myosin chaperone A (UNC45A) and unc-45 myosin chaperone B (UNC45B). The variants identified contribute to function of extracellular matrix and cardiomyocytes., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
16. Collagen prolyl 4-hydroxylase isoenzymes I and II have sequence specificity towards different X-Pro-Gly triplets.
- Author
-
Salo AM, Rappu P, Koski MK, Karjalainen E, Izzi V, Drushinin K, Miinalainen I, Käpylä J, Heino J, and Myllyharju J
- Subjects
- Collagen Type I genetics, Procollagen-Proline Dioxygenase genetics, Procollagen-Proline Dioxygenase chemistry, Procollagen-Proline Dioxygenase metabolism, Collagen genetics, Collagen metabolism, Proline metabolism, Prolyl Hydroxylases genetics, Isoenzymes genetics, Dipeptides
- Abstract
Collagen biosynthesis requires several co- and post-translational modifications of lysine and proline residues to form structurally and functionally competent collagen molecules. Formation of 4-hydroxyproline (4Hyp) in Y-position prolines of the repetitive -X-Y-Gly- sequences provides thermal stability for the triple-helical collagen molecules. 4Hyp formation is catalyzed by a collagen prolyl 4-hydroxylase (C-P4H) family consisting of three isoenzymes. Here we identify specific roles for the two main C-P4H isoenzymes in collagen hydroxylation by a detailed 4Hyp analysis of type I and IV collagens derived from cell and tissue samples. Loss of C-P4H-I results in underhydroxylation of collagen where the affected prolines are not uniformly distributed, but mainly present in sites where the adjacent X-position amino acid has a positively charged or a polar uncharged side chain. In contrast, loss of C-P4H-II results in underhydroxylation of triplets where the X-position is occupied by a negatively charged amino acid glutamate or aspartate. Hydroxylation of these triplets was found to be important as loss of C-P4H-II alone resulted in reduced collagen melting temperature and altered assembly of collagen fibrils and basement membrane. The observed C-P4H isoenzyme differences in substrate specificity were explained by selective binding of the substrate to the active site resulting in distinct differences in Km and Vmax values. Furthermore, our results clearly show that the substrate proline selection is not dependent on the collagen type, but the main determinant is the X-position amino acid of the -X-Pro-Gly- triplet. Although our data clearly shows the necessity of both C-P4H-I and II for normal prolyl 4-hydroxylation and function of collagens, the mRNA expression of the isoenzymes with various procollagens was, surprisingly, not tightly coordinated, suggesting additional levels of control. In conclusion, this study provides a molecular level explanation for the need of multiple C-P4H isoenzymes to generate collagen molecules capable to assemble into intact extracellular matrix structures., Competing Interests: Declaration of Competing Interest J. M. owns equity in FibroGen Inc, which develops P4H inhibitors as potential therapeutics. This company has supported research in the J.M. group., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
17. TGF-β induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids.
- Author
-
Fernandes S, Oliver-De La Cruz J, Morazzo S, Niro F, Cassani M, Ďuríková H, Caravella A, Fiore P, Azzato G, De Marco G, Lauria A, Izzi V, Bosáková V, Fric J, Filipensky P, and Forte G
- Subjects
- Male, Humans, Epithelial-Mesenchymal Transition, Extracellular Matrix metabolism, Prostate metabolism, Cell Line, Tumor, Transforming Growth Factor beta metabolism, Prostatic Neoplasms pathology
- Abstract
Extracellular matrix (ECM) tumorigenic alterations resulting in high matrix deposition and stiffening are hallmarks of adenocarcinomas and are collectively defined as desmoplasia. Here, we thoroughly analysed primary prostate cancer tissues obtained from numerous patients undergoing radical prostatectomy to highlight reproducible structural changes in the ECM leading to the loss of the glandular architecture. Starting from patient cells, we established prostate cancer tumoroids (PCTs) and demonstrated they require TGF-β signalling pathway activity to preserve phenotypical and structural similarities with the tissue of origin. By modulating TGF-β signalling pathway in PCTs, we unveiled its role in ECM accumulation and remodelling in prostate cancer. We also found that TGF-β-induced ECM remodelling is responsible for the initiation of prostate cell epithelial-to-mesenchymal transition (EMT) and the acquisition of a migratory, invasive phenotype. Our findings highlight the cooperative role of TGF-β signalling and ECM desmoplasia in prompting prostate cell EMT and promoting tumour progression and dissemination., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interests., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
18. Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.
- Author
-
Devarajan R, Izzi V, Peltoketo H, Rask G, Kauppila S, Väisänen MR, Ruotsalainen H, Martínez-Nieto G, Karppinen SM, Väisänen T, Kaur I, Koivunen J, Sasaki T, Winqvist R, Manninen A, Wärnberg F, Sund M, Pihlajaniemi T, and Heljasvaara R
- Subjects
- Mice, Animals, Humans, Female, Phosphatidylinositol 3-Kinases metabolism, Receptor, ErbB-2 metabolism, Cell Transformation, Neoplastic, Signal Transduction, Collagen Type XVIII metabolism, Breast Neoplasms drug therapy, Breast Neoplasms genetics, Breast Neoplasms metabolism
- Abstract
The tumor extracellular matrix (ECM) critically regulates cancer progression and treatment response. Expression of the basement membrane component collagen XVIII (ColXVIII) is induced in solid tumors, but its involvement in tumorigenesis has remained elusive. We show here that ColXVIII was markedly upregulated in human breast cancer (BC) and was closely associated with a poor prognosis in high-grade BCs. We discovered a role for ColXVIII as a modulator of epidermal growth factor receptor tyrosine kinase (ErbB) signaling and show that it forms a complex with ErbB1 and -2 (also known as EGFR and human epidermal growth factor receptor 2 [HER2]) and α6-integrin to promote cancer cell proliferation in a pathway involving its N-terminal portion and the MAPK/ERK1/2 and PI3K/AKT cascades. Studies using Col18a1 mouse models crossed with the mouse mammary tumor virus-polyoma virus middle T antigen (MMTV-PyMT) mammary carcinogenesis model showed that ColXVIII promoted BC growth and metastasis in a tumor cell-autonomous manner. Moreover, the number of mammary cancer stem cells was significantly reduced in the MMTV-PyMT and human cell models upon ColXVIII inhibition. Finally, ablation of ColXVIII substantially improved the efficacy of ErbB-targeting therapies in both preclinical models. In summary, ColXVIII was found to sustain the stemness properties of BC cells and tumor progression and metastasis through ErbB signaling, suggesting that targeting ColXVIII in the tumor milieu may have important therapeutic potential.
- Published
- 2023
- Full Text
- View/download PDF
19. Matrisome AnalyzeR - a suite of tools to annotate and quantify ECM molecules in big datasets across organisms.
- Author
-
Petrov PB, Considine JM, Izzi V, and Naba A
- Subjects
- Cell Movement, Extracellular Matrix metabolism, Extracellular Matrix Proteins genetics, Extracellular Matrix Proteins metabolism
- Abstract
The extracellular matrix (ECM) is a complex meshwork of proteins that forms the scaffold of all tissues in multicellular organisms. It plays crucial roles in all aspects of life - from orchestrating cell migration during development, to supporting tissue repair. It also plays critical roles in the etiology or progression of diseases. To study this compartment, we have previously defined the compendium of all genes encoding ECM and ECM-associated proteins for multiple organisms. We termed this compendium the 'matrisome' and further classified matrisome components into different structural or functional categories. This nomenclature is now largely adopted by the research community to annotate '-omics' datasets and has contributed to advance both fundamental and translational ECM research. Here, we report the development of Matrisome AnalyzeR, a suite of tools including a web-based application and an R package. The web application can be used by anyone interested in annotating, classifying and tabulating matrisome molecules in large datasets without requiring programming knowledge. The companion R package is available to more experienced users, interested in processing larger datasets or in additional data visualization options., Competing Interests: Competing interests The authors declare no competing or financial interests., (© 2023. Published by The Company of Biologists Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
20. Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.
- Author
-
Rafaeva M, Jensen ARD, Horton ER, Zornhagen KW, Strøbech JE, Fleischhauer L, Mayorca-Guiliani AE, Nielsen SR, Grønseth DS, Kuś F, Schoof EM, Arnes L, Koch M, Clausen-Schaumann H, Izzi V, Reuten R, and Erler JT
- Subjects
- Humans, Prognosis, Fibroblasts metabolism, Extracellular Matrix Proteins, Pancreatic Neoplasms, Pancreatic Neoplasms pathology, Carcinoma, Pancreatic Ductal pathology
- Abstract
The desmoplastic reaction observed in many cancers is a hallmark of disease progression and prognosis, particularly in breast and pancreatic cancer. Stromal-derived extracellular matrix (ECM) is significantly altered in desmoplasia, and as such plays a critical role in driving cancer progression. Using fibroblast-derived matrices (FDMs), we show that cancer cells have increased growth on cancer associated FDMs, when compared to FDMs derived from non-malignant tissue (normal) fibroblasts. We assess the changes in ECM characteristics from normal to cancer-associated stroma at the primary tumor site. Compositional, structural, and mechanical analyses reveal significant differences, with an increase in abundance of core ECM proteins, coupled with an increase in stiffness and density in cancer-associated FDMs. From compositional changes of FDM, we derived a 36-ECM protein signature, which we show matches in large part with the changes in pancreatic ductal adenocarcinoma (PDAC) tumor and metastases progression. Additionally, this signature also matches at the transcriptomic level in multiple cancer types in patients, prognostic of their survival. Together, our results show relevance of FDMs for cancer modelling and identification of desmoplastic ECM components for further mechanistic studies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Rafaeva, Jensen, Horton, Zornhagen, Strøbech, Fleischhauer, Mayorca-Guiliani, Nielsen, Grønseth, Kuś, Schoof, Arnes, Koch, Clausen-Schaumann, Izzi, Reuten and Erler.)
- Published
- 2023
- Full Text
- View/download PDF
21. Cooperation of Angiopoietin-2 and Angiopoietin-4 in Schlemm's Canal Maintenance.
- Author
-
Kapiainen E, Elamaa H, Miinalainen I, Izzi V, and Eklund L
- Subjects
- Angiopoietin-1 genetics, Angiopoietin-1 metabolism, Animals, Aqueous Humor metabolism, Intraocular Pressure, Mice, Tamoxifen, Trabecular Meshwork metabolism, Angiopoietin-2 genetics, Angiopoietin-2 metabolism, Angiopoietins genetics, Glaucoma pathology
- Abstract
Purpose: Defects in the iridocorneal angle tissues, including the trabecular meshwork (TM) and Schlemm's canal (SC), impair aqueous humor flow and increase the intraocular pressure (IOP), eventually resulting in glaucoma. Activation of endothelial tyrosine kinase receptor Tie2 by angiopoietin-1 (Angpt1) has been demonstrated to be essential for SC formation, but roles of the other two Tie2 ligands, Angpt2 and Angpt4, have been controversial or not yet characterized, respectively., Methods: Angpt4 expression was investigated using genetic cell fate mapping and reporter mice. Congenital deletion of Angpt2 and Angpt4 and tamoxifen-inducible deletion of Angpt1 in mice were used to study the effects of Angpt4 deletion alone and in combination with the other angiopoietins. SC morphology was examined with immunofluorescent staining. IOP measurements, electron microscopy, and histologic evaluation were used to study glaucomatous changes., Results: Angpt4 was postnatally expressed in the TM. While Angpt4 deletion alone did not affect SC and Angpt4 deletion did not aggravate Angpt1 deletion phenotype, absence of Angpt4 combined with Angpt2 deletion had detrimental effects on SC morphology in adult mice. Consequently, Angpt2-/-;Angpt4-/- mice displayed glaucomatous changes in the eye. Mice with Angpt2 deletion alone showed only moderate SC defects, but Angpt2 was necessary for proper limbal vasculature development. Mechanistically, analysis of Tie2 phosphorylation suggested that Angpt2 and Angpt4 cooperate as agonistic Tie2 ligands in maintaining SC integrity., Conclusions: Our results indicated an additive effect of Angpt4 in SC maintenance and Tie2 activation and a spatiotemporally regulated interplay between the angiopoietins in the mouse iridocorneal angle.
- Published
- 2022
- Full Text
- View/download PDF
22. Advances on the roles of tenascin-C in cancer.
- Author
-
Yilmaz A, Loustau T, Salomé N, Poilil Surendran S, Li C, Tucker RP, Izzi V, Lamba R, Koch M, and Orend G
- Subjects
- Animals, Carcinogenesis genetics, Carcinogenesis metabolism, Extracellular Matrix metabolism, Mice, Neoplasms genetics, Neoplasms metabolism, Tenascin genetics, Tenascin metabolism
- Abstract
The roles of the extracellular matrix molecule tenascin-C (TNC) in health and disease have been extensively reviewed since its discovery over 40 years ago. Here, we will describe recent insights into the roles of TNC in tumorigenesis, angiogenesis, immunity and metastasis. In addition to high levels of expression in tumors, and during chronic inflammation, and bacterial and viral infection, TNC is also expressed in lymphoid organs. This supports potential roles for TNC in immunity control. Advances using murine models with engineered TNC levels were instrumental in the discovery of important functions of TNC as a danger-associated molecular pattern (DAMP) molecule in tissue repair and revealed multiple TNC actions in tumor progression. TNC acts through distinct mechanisms on many different cell types with immune cells coming into focus as important targets of TNC in cancer. We will describe how this knowledge could be exploited for cancer disease management, in particular for immune (checkpoint) therapies., Competing Interests: Competing interests G.O. has filed patents on the discovery of TNC targeting peptides (WO2021233766A1) and nanobodies (EP21305210.3). All other authors declare no competing or financial interests., (© 2022. Published by The Company of Biologists Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
23. Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis.
- Author
-
Martínez-Nieto GA, Teppo HR, Petrelius N, Izzi V, Devarajan R, Petäistö T, Liu H, Kim KS, Karppinen SM, Ruotsalainen H, Koivunen J, Mäki JM, Walker GC, Pihlajaniemi T, Gullberg D, and Heljasvaara R
- Abstract
Integrin α11β1 is a collagen-binding integrin that is needed to induce and maintain the myofibroblast phenotype in fibrotic tissues and during wound healing. The expression of the α11 is upregulated in cancer-associated fibroblasts (CAFs) in various human neoplasms. We investigated α11 expression in human cutaneous squamous cell carcinoma (cSCC) and in benign and premalignant human skin lesions and monitored its effects on cSCC development by subjecting α11-knockout ( Itga11
-/- ) mice to the DMBA/TPA skin carcinogenesis protocol. α11-deficient mice showed significantly decreased tumor cell proliferation, leading to delayed tumor development and reduced tumor burden. Integrin α11 expression was significantly upregulated in the desmoplastic tumor stroma of human and mouse cSCCs, and the highest α11 expression was detected in high-grade tumors. Our results point to a reduced ability of α11-deficient stromal cells to differentiate into matrix-producing and tumor-promoting CAFs and suggest that this is one causative mechanism underlying the observed decreased tumor growth. An unexpected finding in our study was that, despite reduced CAF activation, the α11-deficient skin tumors were characterized by the presence of thick and regularly aligned collagen bundles. This finding was attributed to a higher expression of TGFβ1 and collagen crosslinking lysyl oxidases in the Itga11-/- tumor stroma. In summary, our data suggest that α11β1 operates in a complex interactive tumor environment to regulate ECM synthesis and collagen organization and thus foster cSCC growth. Further studies with advanced experimental models are still needed to define the exact roles and molecular mechanisms of stromal α11β1 in skin tumorigenesis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Martínez-Nieto, Teppo, Petrelius, Izzi, Devarajan, Petäistö, Liu, Kim, Karppinen, Ruotsalainen, Koivunen, Mäki, Walker, Pihlajaniemi, Gullberg and Heljasvaara.)- Published
- 2022
- Full Text
- View/download PDF
24. The alternative matrisome: Alternative splicing of ECM proteins in development, homeostasis and tumor progression.
- Author
-
Rekad Z, Izzi V, Lamba R, Ciais D, and Van Obberghen-Schilling E
- Subjects
- Alternative Splicing, Extracellular Matrix genetics, Extracellular Matrix metabolism, Homeostasis genetics, Humans, Extracellular Matrix Proteins genetics, Extracellular Matrix Proteins metabolism, Neoplasms genetics, Neoplasms metabolism
- Abstract
The extracellular matrix (ECM) is a fundamental component of the tissue of multicellular organisms that is comprised of an intricate network of multidomain proteins and associated factors, collectively known as the matrisome. The ECM creates a biophysical environment that regulates essential cellular processes such as adhesion, proliferation and migration and impacts cell fate decisions. The composition of the ECM varies across organs, developmental stages and diseases. Interestingly, most ECM genes generate transcripts that undergo extensive alternative splicing events, producing multiple protein variants from one gene thus enhancing ECM complexity and impacting matrix architecture. Extensive studies over the past several decades have linked ECM remodeling and expression of alternatively spliced ECM isoforms to cancer, and reprogramming of the alternative splicing patterns in cells has recently been proposed as a new hallmark of tumor progression. Indeed, tumor-associated alternative splicing occurs in both malignant and non-malignant cells of the tumor environment and growing evidence suggests that expression of specific ECM splicing variants could be a key step for stromal activation. In this review, we present a general overview of alternative splicing mechanisms, featuring examples of ECM components. The importance of ECM variant expression during essential physiological processes, such as tissue organization and embryonic development is discussed as well as the dysregulation of alternative splicing in cancer. The overall aim of this review is to address the complexity of the ECM by highlighting the importance of the yet-to-be-fully-characterized "alternative" matrisome in physiological and pathological states such as cancer., Competing Interests: Declaration of Competing Interest The authors declare no competing interests., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
25. Analysis of extracellular matrix network dynamics in cancer using the MatriNet database.
- Author
-
Kontio J, Soñora VR, Pesola V, Lamba R, Dittmann A, Navarro AD, Koivunen J, Pihlajaniemi T, and Izzi V
- Subjects
- Carcinogenesis metabolism, Extracellular Matrix Proteins genetics, Extracellular Matrix Proteins metabolism, Humans, Tumor Microenvironment, Extracellular Matrix metabolism, Neoplasms metabolism
- Abstract
The extracellular matrix (ECM) is a three-dimensional network of proteins of diverse nature, whose interactions are essential to provide tissues with the correct mechanical and biochemical cues they need for proper development and homeostasis. Changes in the quantity of extracellular matrix (ECM) components and their balance within the tumor microenvironment (TME) accompany and fuel all steps of tumor development, growth and metastasis, and a deeper and more systematic understanding of these processes is fundamental for the development of future therapeutic approaches. The wealth of "big data" from numerous sources has enabled gigantic steps forward in the comprehension of the oncogenic process, also impacting on our understanding of ECM changes in the TME. Most of the available studies, however, have not considered the network nature of ECM and the possibility that changes in the quantity of components might be regulated (co-occur) in cancer and significantly "rebound" on the whole network through its connections, fundamentally altering the matrix interactome. To facilitate the exploration of these network-scale effects we have implemented MatriNet (www.matrinet.org), a database enabling the study of structural changes in ECM network architectures as a function of their protein-protein interaction strengths across 20 different tumor types. The use of MatriNet is intuitive and offers new insights into tumor-specific as well as pan-cancer features of ECM networks, facilitating the identification of similarities and differences between cancers as well as the visualization of single-tumor events and the prioritization of ECM targets for further experimental investigations., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
26. Reduced Bone Mass in Collagen Prolyl 4-Hydroxylase P4ha1 +/- ; P4ha2 -/- Compound Mutant Mice.
- Author
-
Tolonen JP, Salo AM, Finnilä M, Aro E, Karjalainen E, Ronkainen VP, Drushinin K, Merceron C, Izzi V, Schipani E, and Myllyharju J
- Abstract
Proper deposition of the extracellular matrix and its major components, the collagens, is essential for endochondral ossification and bone mass accrual. Collagen prolyl 4-hydroxylases (C-P4Hs) hydroxylate proline residues in the -X-Pro-Gly- repeats of all known collagen types. Their product, 4-hydroxyproline, is essential for correct folding and thermal stability of the triple-helical collagen molecules in physiological body temperatures. We have previously shown that inactivation of the mouse P4ha1 gene, which codes for the catalytic α subunit of the major C-P4H isoform, is embryonic lethal, whereas inactivation of the P4ha2 gene produced only a minor phenotype. Instead, mice with a haploinsufficiency of the P4ha1 gene combined with a homozygous deletion of the P4ha2 gene present with a moderate chondrodysplasia due to transient cell death of the growth plate chondrocytes. Here, to further characterize the bone phenotype of the P4ha1
+/- ; P4ha2-/- mice, we have carried out gene expression analyses at whole-tissue and single-cell levels, biochemical analyses, microcomputed tomography, histomorphometric analyses, and second harmonic generation microscopy to show that C-P4H α subunit expression peaks early and that the C-P4H deficiency leads to reduced collagen amount, a reduced rate of bone formation, and a loss of trabecular and cortical bone volume in the long bones. The total osteoblast number in the proximal P4ha1+/- ; P4ha2-/- tibia and the C-P4H activity in primary P4ha1+/- ; P4ha2-/- osteoblasts were reduced, whereas the population of osteoprogenitor colony-forming unit fibroblasts was increased in the P4ha1+/- ; P4ha2-/- marrow. Thus, the P4ha1+/- ; P4ha2-/- mouse model recapitulates key aspects of a recently recognized congenital connective tissue disorder with short stature and bone dysplasia caused by biallelic variants of the human P4HA1 gene. Altogether, the data demonstrate the allele dose-dependent importance of the C-P4Hs to the developing organism and a threshold effect of C-P4H activity in the proper production of bone matrix. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., (© 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.)- Published
- 2022
- Full Text
- View/download PDF
27. Mutations in the COL18A1 gen associated with knobloch syndrome and structural brain anomalies: a novel case report and literature review of neuroimaging findings.
- Author
-
Irene Díez García-Prieto I, Lopez-Martín S, Albert J, Jiménez de la Peña M, Fernández-Mayoralas DM, Calleja-Pérez B, Gómez Fernández MT, Álvarez S, Pihlajaniemi T, Izzi V, and Fernández-Jaén A
- Subjects
- Cerebellum, Child, Preschool, Encephalocele, Humans, Male, Mutation, Neuroimaging, Retinal Degeneration, Retinal Detachment congenital, Collagen Type XVIII genetics, Endostatins genetics
- Abstract
. COL18A1 gene mutations have been associated with Knobloch syndrome, which is characterized by ocular and brain abnormalities. Here we report a 4.5 years-old male child with autism and two novel COL18A1 mutations (NM_030582.4: c.1883_1891dup and c.1787C>T). Hypermetropic astigmatism, but not brain migration disorders, was observed. However, an asymmetric pattern of cerebellar perfusion and a smaller arcuate fascicle were found. Low levels of collagen XVIII were also observed in the patient´s serum. Thus, biallelic loss-of-function mutations in COL18A1 may be a new cause of autism without the brain malformations typically reported in patients with Knobloch syndrome.
- Published
- 2022
- Full Text
- View/download PDF
28. Corrigendum to "Evidence for discrete modes of YAP1 signaling via mRNA splice isoforms in development and disease" [Genomics 113 (2021) 1349-1365].
- Author
-
Vrbský J, Vinarský V, Perestrelo AR, Oliver-De La Cruz J, Martino F, Pompeiano A, Izzi V, Hlinomaz O, Rotrekl V, Sudol M, Pagliari S, and Forte G
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.